Niva Bupa Health
Niva Bupa Health Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
October saw over 50% growth in retail sales, driven by GST reduction from 18% to 0%, enhancing affordability and demand. Growth with profit remains the company’s core mantra as they continue to invest in health insurance opportunities.
From Niva Bupa Health's Q2 FY26 earnings-call transcript · updated 26 Aug 2026.
Revenue & Sales Performance
- October saw over 50% growth in retail sales, driven by GST reduction from 18% to 0%, enhancing affordability and demand.
- Increased renewal rates, with October renewal rates higher by 100 basis points versus last year.
- Retail health grew 28% in H1, with approximately 20% of growth from volume (more lives covered) and 7% from ticket size improvement.
- Strong growth in SME segment within group health, close to 50% growth, contributing around 70-75% of group policies by volume.
- Multi-channel approach driving SME growth including digital, agency, brokers, and banks.
- Anticipate continued growth from improved conversion rates, digital channels performing 1.5x average organization growth.
2 more points from Niva Bupa Health's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Niva Bupa Health said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Niva Bupa is making significant investments to pursue health insurance growth with profit as their mantra.
- Increased distribution headcount by more than 1,000 field staff this year.
- Set up an AI lab to explore capabilities offered by Generative AI, including customer projects recognized globally.
- Launched ReAssure 3.0, a modern microservices-based core system aimed at transforming product launch and customer service.
- Investments focus on sales, customer experience enhancement, and cost optimization.
2 more points from Niva Bupa Health's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Insurance
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Niva Bupa Health said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Niva Bupa Health — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.1K Cr, net profit ₹345 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Niva Bupa Health Insurance Company Ltd's management said in earlier quarters
Others in Insurance this season
- New India Assura (Q2 FY26)
New India Assurance recorded strong growth in H1 FY'26 with an 11.5% increase in Gross Written Premium (GWP), outpacing industry growth of 7.3%. Key concall…
- Star Health Insu (Q2 FY26)
Fresh business growth robust, with about 50% growth in new policies noted in October. Key concall takeaways from Star Health & Allied Insurance Company Ltd's…
- Medi Assist Healthcare Services Ltd (Q2 FY26)
The partnership with Star Health for the MAtrix claims platform shows promising volume migration, currently at 40%, with full migration ongoing. Key concall…
- Life Insurance (Q2 FY26)
Individual New Business Premium (NBP) rose 67%, propelled by bancassurance and alternate channels, with new tie-ups (e.g., AU Small Finance Bank) contributing…
Arthneeti Pro · Annual
Niva Bupa Health and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Niva Bupa Health Q2 FY26 results?
October saw over 50% growth in retail sales, driven by GST reduction from 18% to 0%, enhancing affordability and demand. Growth with profit remains the company’s core mantra as they continue to invest in health insurance opportunities.
What is Niva Bupa Health share price analysis?
Niva Bupa Health currently shows a neutral. The stock trades at a P/E of 87.7 with a market cap of ₹15,278 Cr. Investors should review the full earnings analysis for detailed insights.
Is Niva Bupa Health planning capital expenditure?
Niva Bupa is making significant investments to pursue health insurance growth with profit as their mantra.
Keep Niva Bupa Health on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.